Main Menu

NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Trillium Therapeutics Inc (TO: TRIL)

 
TRIL Technical Analysis
4
As on 19th Nov 2021 TRIL STOCK Price closed @ 23.33 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 14.74 & Buy for SHORT-TERM with Stoploss of 19.20 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

TRILSTOCK Price

Open 23.22 Change Price %
High 23.45 1 Day 0.11 0.47
Low 23.22 1 Week 1.06 4.76
Close 23.33 1 Month 0.93 4.15
Volume 60423 1 Year 5.17 28.47
52 Week High 26.40 | 52 Week Low 7.51
 
TO Canada Most Active Stocks
YRI 7.89 0.13%
UEX 0.50 16.28%
RY 172.33 %
CVE 22.94 %
BNS 72.78 %
TD 77.32 %
SJR-B 40.48 0.02%
BMO 129.54 %
MFC 41.89 %
FCU 0.92 %
 
TO Canada Top Gainers Stocks
UEX 0.50 16.28%
ORL 8.97 10.74%
ORL 8.97 10.74%
ORL 8.97 10.74%
ORL 8.97 10.74%
ORL 8.97 10.74%
ORL 8.97 10.74%
ORL 8.97 10.74%
CPI 0.44 10.00%
CPI 0.44 10.00%
 
TO Canada Top Losers Stocks
CWEB-WR 0.10 -16.67%
GTMS 0.97 -15.65%
AQA 0.08 -11.11%
AQA 0.08 -11.11%
AQA 0.08 -11.11%
AQA 0.08 -11.11%
RET-A 1.43 -10.62%
RET-A 1.43 -10.62%
TRL 0.24 -7.69%
TRL 0.24 -7.69%
 
 
TRIL
Daily Charts		 TRIL
Intraday Charts		 Whats New @
Bazaartrend		 TRIL
Free Analysis
 
TRIL Important Levels Intraday
RESISTANCE23.77
RESISTANCE23.63
RESISTANCE23.54
RESISTANCE23.46
SUPPORT23.20
SUPPORT23.12
SUPPORT23.03
SUPPORT22.89
 
TRIL Forecast October 2024
Share
4th UP Forecast45.14
3rd UP Forecast38.15
2nd UP Forecast33.82
1st UP Forecast29.5
1st DOWN Forecast17.16
2nd DOWN Forecast12.84
3rd DOWN Forecast8.51
4th DOWN Forecast1.52
 
TRIL Weekly Forecast
4th UP Forecast27.63
3rd UP Forecast26.25
2nd UP Forecast25.40
1st UP Forecast24.55
1st DOWN Forecast22.11
2nd DOWN Forecast21.26
3rd DOWN Forecast20.41
4th DOWN Forecast19.03
 
TRIL Forecast2024
4th UP Forecast61.18
3rd UP Forecast49.04
2nd UP Forecast41.54
1st UP Forecast34.03
1st DOWN Forecast12.63
2nd DOWN Forecast5.12
3rd DOWN Forecast-2.38
4th DOWN Forecast-14.52
 
 
TRIL Other Details
Segment EQ
Market Capital 2337188608.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
TRIL Address
TRIL
 
TRIL Latest News
 
Your Comments and Response on Trillium Therapeutics Inc
 
TRIL Business Profile
Trillium Therapeutics Inc., a clinical stage immuno-oncology company, develops therapies for the treatment of cancer. Its include TTI-622, a SIRPa-IgG4 Fc fusion protein that is designed to enhance macrophage-mediated phagocytosis and anti-tumor activity by blocking the CD47, which is in Phase 1 clinical trials; and TTI-621, a SIRPa-IgG1 Fc fusion protein, which is in Phase 1 clinical trials and generates a signal blocking the CD47 for advanced relapsed or refractory hematologic malignancies, and solid tumors and mycosis fungoides. The company was formerly known as Stem Cell Therapeutics Corp. and changed its name to Trillium Therapeutics Inc. in June 2014. Trillium Therapeutics Inc. was incorporated in 2004 is based in Cambridge, Massachusetts. Address: 2488 Dunwin Drive, Mississauga, ON, Canada, L5L 1J9
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service